Industry Perspectives: Concept of Smart ICSRs.
As the Biopharmaceutical Industry moves towards digitalization of the R&D landscape, the classical way of doing Pharmacovigilance will have to change. It is now widely accepted that we cannot wish away ICSRs. Organizations will have to move towards the concept of ‘’Smart ICSRs’’.
Signal Detection Innovation Boosts Safety and Uncovers Commercial Opportunities
Elizabeth Smalley, Director of Product Management, Data & Analytics at ArisGlobal, explains how the benefits of proactive signal detection, via intelligent analysis of extensive and robust real-world data, go beyond faster and more accurate pharmacovigilance.
Podcast: Role of AI in Driving Patient-Centric Drug Development
ArisGlobal’s Senior VP of Safety and Medical, Beena Wood, joined the Empowered Patient Podcast with Karen Jagoda. Beena highlights how artificial intelligence is revolutionizing patient-centricity in drug development, pointing out the factors drawing more interest in this challenge.
How CROs are Uniquely Positioned to Drive Adoption of the TMF Exchange Mechanism
“By leveraging the TMF Reference Model and eTMF Exchange Mechanism Standard, CROs have the power to drive best practices within a variety of therapeutic areas, not only informing the TMF Reference Model itself but also the industry at large.”
In the News
Read the latest thought leadership and contributed content from our people.
In the News
GCP update: advice on what to expect and how to prepareLifeSphere’s head of clinical product management, Sonia Araujo, weighs in on the GCP updates in an interview with Outsourcing Pharma. Read the full piece here.
Learn MoreIn the News
Data Fabric: Make Safety a Strategic Center by Unlocking ValueOur VP of Safety, Beena Wood, shares the power of a well-oiled data fabric. Read the article here.
Learn MoreIn the News
How CROs are Uniquely Positioned to Drive Adoption of the TMF Exchange MechanismOur Director of Product Marketing – Clinical, Art Brown, shares insights on the CRO opportunity with TMF exchange. Read more on Applied Clinical Trials here.
Learn MorePress Releases
From product news to customer welcomes, executive announcements to event attendance – browse all of our press releases here.
Press Releases
Montreal CRO MHICC Chooses LifeSphere® Safety to Process Adverse Event Cases as Part of Its Expansion into Post-Market ServicesMontreal Health Innovations Coordinating Center (MHICC), a fast-growing contract research organization, believes LifeSphere’s innovative use of automation and Generative AI is aligned with its pharmacovigilance plans.
Learn MorePress Releases
Newest Version of LifeSphere® Regulatory Platform Allows Organizations to Leverage Latest GenAI TechnologyEnd-to-end functionality helps cut skyrocketing costs of compliance and removes workflow inefficiencies.
Learn MorePress Releases
Top 5 Global Biotech Company Goes Live with LifeSphere® MultiVigilance and Reporting & Analytics SolutionThe top-tier life sciences company will standardize its Safety operations on the cloud-powered technology platform, LifeSphere, which is propelling life sciences GenAI use cases.
Learn MoreBlog
Blog
GenAI’s large language models will transform safety & regulatory processesUp to now, AI technology has had to be painstakingly ‘trained’ in what to look for. This training burden has largely inhibited its use to transform labor-intensive Safety and Regulatory processes in life sciences R&D.
Learn MoreBlog
Embracing the Cloud: A Transformative Journey in Regulatory OperationsIn the ever-evolving world of pharmaceuticals, a leading company has embarked on a transformative journey by moving its regulatory operations to the cloud. This shift from traditional on-premise systems to a cloud platform has revolutionized regulatory data management. This blog explores the details of this significant transition, highlighting the process,…
Learn MoreBlog
Transforming Medical Affairs Engagement with Generative AIIn today’s rapidly evolving landscape of medical affairs, stakeholder engagement extends beyond key opinion leaders to include community physicians, payers, and other value-based decision-makers. Generative AI (GenAI) is at the forefront of this transformation, offering personalized and scalable engagement strategies. Let’s explore how medical affairs can leverage these innovations to…
Learn More
ArisGlobal awarded Frost & Sullivan 2021 North America customer value leadership
ArisGlobal recognized by Frost & Sullivan for enabling life sciences companies to accelerate R&D with its LifeSphere platform.
Events
Event
Breakthrough ShanghaiJuly 25th, 2024 | Shanghai, China Location: Fairmont Peace Hotel Breakthrough Innovators is a series of global events to bring customers together in their region to discuss key topics and insights that matter. …
Learn MoreEvent
Revolutionizing Your PV Case Intake with Gen AI and Advanced AutomationJune 26, 2024 | Webinar Advanced Intake is a groundbreaking solution that revolutionizes traditional PV case intake. Powered by our next-generation LifeSphere NavaX cognitive computing engine, Advanced Intake seamlessly integrates with your existing infrastructure to give your teams access to cutting-edge GenAI-powered automation to streamline data collection from diverse sources.
Learn MoreResources
Download the Media Kit
Access fast facts and resources about our company’s decades of innovation.
Contact Our Media Team
Connect with our team at in-person and virtual events, including Breakthrough.
Get the latest news from ArisGlobal and our LifeSphere suite of innovation tools.
Leverage the latest GenAI and LLM innovations powered by LifeSphere NavaX 
